(Q24338942)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Fumitaka Kawakami

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Naoki Shimada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Etsuro Ohta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Go Kagiya

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Rei Kawashima

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Hiroko Maruyama

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Takafumi Ichikawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

January 2014

0 references

published in

FEBS Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

3-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

Parkinsonism, Lrrk2 G2019S, and tau neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

The genetics and neuropathology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

LRRK2 I2020T mutation is associated with tau pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

Atypical tauopathy in a patient with LRRK2-G2019S mutation and tremor-dominant Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ß.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3β

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

Biochemical characterization of phospholipids, sulfatide and heparin as potent stimulators for autophosphorylation of GSK-3beta and the GSK-3beta-mediated phosphorylation of myelin basic protein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

Allergy influences the inflammatory status of the brain and enhances tau-phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

I(2020)T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson's disease, has a higher intracellular degradation rate than the wild-type molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12579

21 January 2018

Identifiers

DOI

10.1111/FEBS.12579

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json

release_g2wc7leuzzgrfckk67xccphbmi

3 June 2020

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24165324%20AND%20SRC:MED&resulttype=core&format=json